p.46 抽出テキスト

mance of Coronary CT Angiography and Myocardial Perfusion Imaging in Kidney Transplantation Candidates. JACC Cardiovasc Imaging 2015; 8: 553-562. PMID: 25869350 225. Wang LW, Fahim MA, Hayen A, et al. Cardiac testing for coronary artery disease in potential kidney transplant recipients. Cochrane Database Syst Rev 2011: CD008691. PMID: 22161434 226. Hatta T, Nishimura S, Nishimura T. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging 2009; 36: 1835-1841. PMID: 19471925 227. Wang LW, Masson P, Turner RM, et al. Prognostic value of cardiac tests in potential kidney transplant recipients: A systematic review. Transplantation 2015; 99: 731-745. PMID: 25769066 228. Al-Mallah MH, Hachamovitch R, Dorbala S, et al. Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction. Circ Cardiovasc Imaging 2009; 2: 429-436. PMID: 19920040 229. Murthy VL, Naya M, Foster CR, et al. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging 2012; 5: 1025-1034. PMID: 23058070 230. Kott J, Reichek N, Butler J, et al. Cardiac Imaging in Dialysis Patients. Kidney Med 2020; 2: 629-638. PMID: 33094277 231. Baigent C, Landray MJ, Reith C, et al. SHARP Investigators. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377: 2181-2192. PMID: 21663949 232. Wanner C, Krane V, März W, et al. German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238- 248. PMID: 16034009 233. Fellström BC, Jardine AG, Schmieder RE, et al. AURORA Study

Group. Rosuvastatin and cardiovascular events in patients undergo- ing hemodialysis. N Engl J Med 2009; 360: 1395-1407. PMID: 19332456 234. Tse G, Gong M, Nunez J, et al. International Health Informatics

Study (IHIS) Network. Frailty and Mortality Outcomes After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc 2017; 18: 1097.e1-1097.e10. PMID: 29079033 235. Kojima G, Iliffe S, Taniguchi Y, et al. Prevalence of frailty in Japan: A systematic review and meta-analysis. J Epidemiol 2017; 27: 347- 353. PMID: 28142044 236. Gore MO, Seliger SL, Defilippi CR, et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol 2014; 63: 1441-1448. PMID: 24530665 237. Rozanski A, Berman D. Optimizing the Assessment of Patient Clinical Risk at the Time of Cardiac Stress Testing. JACC Cardiovasc Imaging 2020; 13: 616-623. PMID: 31326497 238. Goldberg RB, Stone NJ, Grundy SM. The 2018 AHA/ACC/ AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/ PCNA Guidelines on the Management of Blood Cholesterol in Diabetes. Diabetes Care 2020; 43: 1673-1678. PMID: 32669405 239. Numasawa Y, Inohara T, Ishii H, et al. J ‐ PCI Registry Investigators. Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10 628 Nonagenarians: Insights From a Japanese Nationwide Registry (J-PCI Registry). J Am Heart Assoc 2019; 8: e011183. PMID: 30791799 240. Varenne O, Cook S, Sideris G, et al. SENIOR investigators. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet 2018; 391: 41- 50. PMID: 29102362 241. Urban P, Meredith IT, Abizaid A, et al. LEADERS FREE Investiga-

tors. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med 2015; 373: 2038-2047. PMID: 26466021